Stratophase wins

Published: 1-Feb-2010
Manufacturing Regulatory Finance Analysis

Stratophase, a UK specialist in chemical and biochemical measurement and detection, has secured

Stratophase, a UK specialist in chemical and biochemical measurement and detection, has secured £2.5m of follow-on funding from existing investor East Hill Management of Providence, Rhode Island in the US.

The additional investment will enable the company, a spin-out from Southampton University, to roll out its SpectroSens real-time monitoring technology, recruit key staff and move to larger premises.

The SpectroSens optical microchip technology is being developed for a number of applications in process measurement and bio-detection, including in-line monitoring of pharmaceutical manufacturing (both small molecule and bio-pharmaceuticals).

The company says a multinational pharmaceutical company is currently evaluating the system.

Stratophase is headed by ceo Dr Richard Williams.




See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Focusing on next-generation biologics

Read more
Outsourced adaptive control techniques are set to minimise development timelines and enhance process robustness

Trending Articles

  1. SCIEX expands integrated software ecosystem with six mass spectrometry workflow collaborations The firm has announced six software collaborations designed to unify instrument control, data processing and compliance within a single analytical environment, with more partnerships set to be revealed at ASMS 2026
  2. BioNTech to cut up to 1860 jobs and end COVID vaccine production in Germany The German biotech has announced it will cease production at its manufacturing sites in Germany and Singapore in its Q1 earnings report, cutting up to 22% of its workforce in the process as it pivots from COVID-19 vaccines to oncology
  3. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Focusing on next-generation biologics

Outsourced adaptive control techniques are set to minimise development timelines and enhance process robustness
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Bioprocess control in line using optical sensing

Process Analytical Techniques (PAT) and Quality by Design (QbD) initiatives are leading the industry to adopt real-time, continuous monitoring techniques that allow better knowledge from inside the process. Historically, process control has been a combination of real-time physical data and off-line, lab-based, analytical sampling with process quality determined after the process is completed. Stratophase has introduced a real-time, in-line optical media sensor that monitors the media’s status and automates glucose feeding
Analysis

Stratophase Ranger enables automated batch feeding

To optimise metabolism and ultimately increase yields in biologics manufacture
You need to be a subscriber to read this article.
Click here to find out more.
Analysis

Get an in-line view with optical fibres

New real time, in-line measurement technologies developed from fibre optics can improve biopharmaceutical process control, enhancing production efficiency, quality and safety by reducing production cycle times, minimising batch rejection, enabling real-time release, increasing the use of automation and facilitating continuous processing. In-line, real-time measurement techniques that provide status monitoring are now being developed to provide the required analytical measurements from within the fermentation media.
Regulatory

Stratophase doubles manufacturing capability

Result of increased demand for SpectroSens technology
Manufacturing

Domino demonstrates an integrated approach to next-generation coding at Interpack 2026

At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing

Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target

BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Subscribe now